肝硬変(Liver Cirrhosis):治療薬開発パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Liver Cirrhosis - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Liver Cirrhosis Overview 8
Therapeutics Development 9
Pipeline Products for Liver Cirrhosis – Overview 9
Pipeline Products for Liver Cirrhosis – Comparative Analysis 10
Liver Cirrhosis – Therapeutics under Development by Companies 11
Liver Cirrhosis – Therapeutics under Investigation by Universities/Institutes 13
Liver Cirrhosis – Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Liver Cirrhosis – Products under Development by Companies 17
Liver Cirrhosis – Products under Investigation by Universities/Institutes 19
Liver Cirrhosis – Companies Involved in Therapeutics Development 20
Alfa Wassermann S.p.A 20
Conatus Pharmaceuticals Inc. 21
Digna Biotech, S.L. 22
Galectin Therapeutics, Inc. 23
Gilead Sciences, Inc. 24
GNI Group Ltd. 25
Pacific Therapeutics Ltd. 26
PharmaIN Corporation 27
Pharmicell Co., Ltd. 28
S-Evans Biosciences, Inc. 29
Stelic Institute & Co. 30
Stempeutics Research Private Limited 31
Liver Cirrhosis – Therapeutics Assessment 32
Assessment by Monotherapy Products 32
Assessment by Combination Products 33
Assessment by Target 34
Assessment by Mechanism of Action 36
Assessment by Route of Administration 38
Assessment by Molecule Type 40
Drug Profiles 42
(sofosbuvir + GS-5816) – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
Cell Therapy for Liver Cirrhosis – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
DB-027 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
DB-036 – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
emricasan – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
F-351 – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
GR-MD-01 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
GR-MD-02 – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
GXHPC-1 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Livercellgram – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Monoclonal Antibodies to Antagonize Transforming Growth Factor Beta 1 for HCV associated Liver Cirrhosis – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
PTL-303 – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Px-104 – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
rifaximin – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
simtuzumab – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
Stem Cell Therapy for Liver Cirrhosis – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Stem Cell Therapy for Liver Cirrhosis – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
Stem Cell Therapy for Metabolic, Gastrointestinal and Respiratory Disorders – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
Stem Cell Therapy for Rheumatoid Arthritis and Liver Cirrhosis – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Stempeucel – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
STNM-04 – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
thrombopoietin – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
Undisclosed Peptide for Liver Cirrhosis – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
Liver Cirrhosis – Recent Pipeline Updates 74
Liver Cirrhosis – Dormant Projects 88
Liver Cirrhosis – Discontinued Products 89
Liver Cirrhosis – Product Development Milestones 90
Featured News & Press Releases 90
Nov 10, 2014: Conatus Pharmaceuticals Presents Late-Breaking Poster At AASLD Annual Meeting 90
Oct 08, 2014: Conatus Pharmaceuticals Announces Acceptance Of Late-Breaking Abstract For AASLD Annual Meeting 91
Sep 02, 2014: Conatus Pharmaceuticals Initiates Phase 2 Trial in Patients with Liver Cirrhosis and Separate Open Label Phase 2 Trial in Cirrhosis Patients with Portal Hypertension 92
Jul 23, 2012: Galectin Therapeutics Receives US Patent for Potential Treatment for Chronic Liver Disease with Fibrosis And Cirrhosis 93
Jan 20, 2011: Stempeutics Research’s Stempeucel LC Recieves DCGI Clearance To Start Phase II Clinical Trial For Liver Cirrhosis 94
Nov 07, 2007: China Patent and Trademark Office Grants Patent for F351, GNI’s Key Therapeutic Product for Liver Disease 94
Appendix 95
Methodology 95
Coverage 95
Secondary Research 95
Primary Research 95
Expert Panel Validation 95
Contact Us 95
Disclaimer 96


【レポート販売概要】

■ タイトル:肝硬変(Liver Cirrhosis):治療薬開発パイプライン動向(2015年上半期版)
■ 英文:Liver Cirrhosis - Pipeline Review, H1 2015
■ 発行日:2015年2月28日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6267IDB
■ 調査対象地域:グローバル
  • 半導体(シリコン)IPの世界市場: 集積回路(IC)IP、システムオンアチップ(SOC) IP
    MarketsandMarkets forecast the global semiconductor IP market to reach USD 7.01 Billion by 2022 from USD 3.09 Billion in 2015, growing at a CAGR of 10.55% between 2016 and 2022. Semiconductor IP core chips are the backbone of all the systems and products that modern day consumers use to communicate, travel, entertain, work, produce energy, and increase comfort. Over the last few decades, the Moore …
  • RFIDの世界市場2018-2022
    About this market The growing demand for smart stores to push market growth during the forecast period. Smart store is a type of brick and mortar retail establishment, which uses smart technologies such as smart cards, facial recognition technology, AI technology and others. RFID technology is used in smart stores for delivery of products and check-out services. The success of smart stores will pr …
  • C型肝炎ウイルス:世界市場(医薬品市場予測及び分析~2022)
    PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin or jaundice. There is no effective vaccine against HCV, so the market is driven by thera …
  • BERCHTOLD Holding GmbH:市場シェア分析
    BERCHTOLD Holding GmbH Market Share Analysis Summary GlobalData’s new report, “BERCHTOLD Holding GmbH Market Share Analysis” provides in-depth information on BERCHTOLD Holding GmbH’s market position in the operating room equipment market. The report also provides data and information on the overall competitive landscape within the operating room equipment market. The report is supplemented with gl …
  • BG-12 (Multiple Sclerosis):市場予測と分析(~2022)
    BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous s …
  • ぜんそく:疫学的予測(~2023)
    EpiCast Report: Asthma - Epidemiology Forecast to 2023 Summary Asthma is a chronic inflammatory lung disease that affects persons of all ages, but most commonly starts in childhood. It is a common long-term condition characterized by narrowing of the airways, leading to airflow limitation and airway hyper-responsiveness whenever the lungs come into contact with endogenous and exogenous irritants. …
  • ダイアライザーの世界市場2017-2021
    About DialyzerThe dialyzer, also known as artificial kidney, is a medical device that is used as a filter in the dialysis process for individuals suffering from renal failure. It consists of the filter membrane, which allows the impure blood to pass through and purifies the blood. Technavio’s analysts forecast the global dialyzer market to grow at a CAGR of 5.98% during the period 2017-2021. [Cove …
  • 世界のキャリアイーサネット機器市場動向(2012-2016)
    TechNavio's analysts forecast the Global Carrier Ethernet Equipment market to grow at a CAGR of 6.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to reduce the total expenditure of service providers. The Global Carrier Ethernet Equipment market has also been witnessing the increasing demand for EADs. However, the interoperability issues c …
  • 加齢黄斑変性(AMD)及びその他の網膜疾患治療薬の世界市場:滲出型(ウェット型)、萎縮型(ドライ型)、糖尿病性網膜症
    Analysis of revenues and R&D prospects for those eye drugs – you explore potentials What’s the future for treating disorders of the retina? Visiongain’s updated study forecasts those pharma revenues. There you find outlooks for sales growth in that industry. You also explore trends, technologies, therapies and opportunities. That report gives revenue predictions to 2025 at overall world market, su …
  • ブラジル/ロシア/インド/中国における心調律管理装置の市場動向(~2020)
    BRIC Cardiac Rhythm Management Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the BRIC Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy …
  • 世界の経肺薬剤送達(Pulmonary Drug Delivery)市場及びパイプラインインサイト
    The demand for new and innovative drug delivery systems has been on a rising trend with the pharmaceutical companies concentrating on developing innovative methods for this area. It is the result of these continued efforts, which have led to the ever rising popularity of pulmonary drug delivery methods across the globe. Pulmonary drug delivery system uses the respiratory tract to deliver drugs int …
  • Pertussis:グローバル臨床試験レビューH2, 2013
    Pertussis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Pertussis Global Clinical Trials Review, H2, 2013" provides data on the Pertussis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pertussis. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
  • 世界のプロジェクトポートフォリオ管理市場:コンポーネント別(ソリューション&サービス)、組織規模別、展開モード別、業種別(エネルギー&ユーティリティ、政府&防衛、製造、ヘルスケア&ライフサイエンス)、地域別
    Growing demand for cloud-based PPM solution to gain a birds view on project operations and resource management are expected to drive the growth of the PPM market The global Project Portfolio Management (PPM) market size is expected to grow from USD 4.0 billion in 2019 to USD 5.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period. The PPM market is driven by …
  • 調整雰囲気包装(MA包装)の世界市場2016-2020
    About Modified Atmosphere Packaging Modified atmosphere packaging provides an optimum atmosphere for increasing the shelf life and maintaining the quality of the food enclosed in it by modifying and altering the atmosphere inside the package. The modification of the atmosphere may be achieved either actively or passively. The active modification requires replacing the air with a controlled and des …
  • 世界のセイボリー及びデリカテッセン(調理済み惣菜)食品市場のニュース及びイベント動向(2014年7月)
    Synopsis The report provides a review of the latest news and key events in the global savory & deli foods market during July 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global savory & deli foods market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest eve …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。